This product detects hereditary hypercholesterolemia risk-related genes including LDLR, APOB, PCSK9, LDLRAP1, ABCG5, and ABCG8, and simultaneously screens for drug-related genes SLCO1B1 and APOE to support clinical diagnosis and assessment.
Manufactured by
China
Cygnus Biosciences was founded by a team from Peking University including Academician Xie Xiaoliang. The company specializes in gene sequencing technology R&D, production and commercialization, with over 100 patents filed in China and internationally. Utilizing proprietary Fluorogenic and ECC error-correction coding sequencing technologies, Cygnus provides gene sequencing platforms and solutions for oncology, microbiology, reproductive health, and food safety applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 1 relevant product
Coyote Bioscience Co.,Ltd
China · 2 relevant products
GENERI BIOTECH s.r.o.
Czech Republic · 6 relevant products
ARCHEM SAGLIK SANAYI VE TICARET A.S
Türkiye · 1 relevant product
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 2 relevant products
Randox Laboratories Ltd.
United Kingdom · 1 relevant product
Anbio Biotechnology Limited
Germany · 2 relevant products
Grifols International, S.A
Spain · 1 relevant product
U-GEN BIOTECHNOLOGY INC.
China · 1 relevant product
Shenzhen HaploX Biotechnology Co., Ltd.
China · 6 relevant products
58 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 110 closest product alternatives
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cardiovascular disease screening and risk stratification. Incorporates genetic and molecular markers for personalized cardiovascular health management.
Coyote Bioscience Co.,Ltd · China
A gene genotyping detection kit for simultaneous analysis of human SLCO1B1 and ApoE genes using PCR with fluorescent probe methodology. It enables genetic testing for precision medicine and disease risk assessment. Available variants: Human SLCO1B1 And ApoE Gene Genotyping Detection Kit (PCR Fluorescent Probe Method).
Coyote Bioscience Co.,Ltd · China
A molecular diagnostics reagent kit for human SLCO1B1 and ApoE gene typing using PCR with fluorescent probes. The kit enables genetic analysis for clinical and metabolic assessment.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for detection of APOE gene polymorphisms (*2A, *13, HapB3, c2846A>T) in human genomic DNA. Uses fluorescently labeled probes for genotyping according to CPIC and DPWG guidelines, enabling pharmacogenetic risk assessment for cardiovascular and neurodegenerative disease management.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for detection of APOB R3500Q mutation in human genomic DNA. Supports diagnosis of familial defective apolipoprotein B-100 and lipid disorder assessment.
ARCHEM SAGLIK SANAYI VE TICARET A.S · Türkiye
Specialized reagents for high-density lipoprotein measurement in lipid profile analysis. These products support cardiovascular risk assessment.
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd · China
Comprehensive multigene panel for hereditary disease identification and cancer risk assessment. Provides clinical-grade analysis with detailed genomic reporting.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for apolipoprotein E genotyping in human genomic DNA. Enables detection of APOE polymorphisms relevant to cardiovascular and neurological disease risk assessment.
Randox Laboratories Ltd. · United Kingdom
Diagnostic tests and genetic screening for familial hypercholesterolemia detection. These products support identification and management of inherited lipid disorders.
Anbio Biotechnology Limited · Germany
Multiplex assay measuring total cholesterol, HDL, LDL, and triglycerides for cardiovascular risk assessment. Supports hyperlipidemia diagnosis and treatment monitoring.
Grifols International, S.A · Spain
A genotyping diagnostic solution for disease risk assessment and clinical decision-making.
U-GEN BIOTECHNOLOGY INC. · China
Molecular diagnostic kits for genetic testing applications across hereditary conditions and disease susceptibility screening. Supports preventive medicine and personalized health assessment protocols.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products